Literature DB >> 17506484

Relationship of serum adiponectin with blood lipids, HbA(1)c, and hs-CRP in type II diabetic postmenopausal women.

Mohammad Taghi Goodarzi1, Hossein Babaahmadi-Rezaei, Manizheh Kadkhodaei-Eliaderani, Shahram Haddadinezhad.   

Abstract

Adipose tissue has been considered an important endocrine organ. Adiponectin secretes from adipose tissue and plays an important role in the regulation of glycemia, beta-oxidation in muscle, and decreased insulin resistance in the liver. The objectives of this study were to compare the levels of adiponectin, hs-C-reactive protein (CRP), HbA1c, and blood lipids among diabetic and healthy postmenopausal women, and to determine the relationship between circulating adiponectin and development of type II diabetes. This case-control study was performed on 28 diabetic and 42 age-matched healthy women. All participants were postmenopausal. Serum adiponectin concentrations, serum triglycerides (TG), cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) concentrations were determined. Blood HbA1c and serum hs-CRP were also measured. Adiponectin levels were significantly decreased (P<0.01) in the diabetic patients as compared to normal control subjects. Adiponectin levels were negatively associated with hs-CRP, LDL-C, HbA1c, TG, and total cholesterol (TC). A positive correlation was observed between adiponectin and HDL-C. The obtained data indicate that diabetic women have lower adiponectin levels compared to healthy women. HbA1c as an indicator of glycemic control has a negative correlation with serum adiponectin. Adiponectin may play an important role in the pathogenesis of diabetes, and may be an independent predictor of the development of diabetes in women. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506484      PMCID: PMC6649100          DOI: 10.1002/jcla.20175

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  21 in total

Review 1.  Adiponectin: more than just another fat cell hormone?

Authors:  Manju Chandran; Susan A Phillips; Theodore Ciaraldi; Robert R Henry
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

Authors:  Norbert Stefan; Barbora Vozarova; Tohru Funahashi; Yuji Matsuzawa; Christian Weyer; Robert S Lindsay; Jack F Youngren; Peter J Havel; Richard E Pratley; Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

4.  Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure.

Authors:  Tsutomu Kazumi; Akira Kawaguchi; Keiko Sakai; Tsutomu Hirano; Gen Yoshino
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

Review 5.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.

Authors:  Anders H Berg; Terry P Combs; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2002-03       Impact factor: 12.015

6.  Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.

Authors:  Makoto Daimon; Toshihide Oizumi; Tamotsu Saitoh; Wataru Kameda; Akihiko Hirata; Hiroshi Yamaguchi; Hiroshi Ohnuma; Masahiko Igarashi; Makoto Tominaga; Takeo Kato
Journal:  Diabetes Care       Date:  2003-07       Impact factor: 19.112

7.  Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians.

Authors:  Chamukuttan Snehalatha; Bheekamchand Mukesh; Mary Simon; Vijay Viswanathan; Steven M Haffner; Ambady Ramachandran
Journal:  Diabetes Care       Date:  2003-12       Impact factor: 19.112

8.  Decreased plasma adiponectin concentrations in women with dyslipidemia.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

9.  Adiponectin and protection against type 2 diabetes mellitus.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

10.  [Inflammatory markers and adiponectin plasma level in patients with type 2 diabetes].

Authors:  Monika Zurawska-Kliś; Józef Drzewoski
Journal:  Pol Arch Med Wewn       Date:  2005-07
View more
  12 in total

1.  Role of group II metabotropic glutamate receptors (mGluR2/3) blockade on long-term potentiation in the dentate gyrus region of hippocampus in rats fed with high-fat diet.

Authors:  Seyed Assad Karimi; Alireza Komaki; Iraj Salehi; Abdolrahman Sarihi; Siamak Shahidi
Journal:  Neurochem Res       Date:  2015-02-06       Impact factor: 3.996

2.  The Association Between Three Adipocytokines (Adiponectin, Resistin and Visfatin) And Thyroid Status in Patients With Type 2 Diabetes Mellitus and Autoimmune Thyroiditis.

Authors:  Š Sotak; Z Schroner; I Lazúrová; M Felšőci; I Jochmanová; D Petrášová; I Bertková; M Mitníková; B Nováková; H Wagnerová; O Bobelová
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

3.  Analysis of the degree of insulin resistance in post menopausal women by using skin temperature measurements and fasting insulin and fasting glucose levels: a case control study.

Authors:  Sathya Bhama C V; Balaji S; Seethalakshmi A
Journal:  J Clin Diagn Res       Date:  2012-12-15

4.  Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women.

Authors:  Robert H Coker; Rick H Williams; Sophie E Yeo; Patrick M Kortebein; Don L Bodenner; Philip A Kern; William J Evans
Journal:  Metab Syndr Relat Disord       Date:  2009-02       Impact factor: 1.894

5.  Adiponectin is a Good Marker for Metabolic State among Type 1 Diabetes Mellitus Patients.

Authors:  Hamdollah Karamifar; Narges Habibian; Gholamhosein Amirhakimi; Zohre Karamizadeh; Abbas Alipour
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

Review 6.  Adiponectin: an adipokine with protective features against metabolic syndrome.

Authors:  Maryam Esfahani; Ahmad Movahedian; Mostafa Baranchi; Mohammad Taghi Goodarzi
Journal:  Iran J Basic Med Sci       Date:  2015-05       Impact factor: 2.699

Review 7.  The Role of Anethum graveolens L. (Dill) in the Management of Diabetes.

Authors:  Mohammad Taghi Goodarzi; Iraj Khodadadi; Heidar Tavilani; Ebrahim Abbasi Oshaghi
Journal:  J Trop Med       Date:  2016-10-18

8.  Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women.

Authors:  Filipa Mascarenhas-Melo; Daniela Marado; Filipe Palavra; José Sereno; Álvaro Coelho; Rui Pinto; Edite Teixeira-Lemos; Frederico Teixeira; Flávio Reis
Journal:  Cardiovasc Diabetol       Date:  2013-04-09       Impact factor: 9.951

9.  Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations.

Authors:  Filipa Mascarenhas-Melo; José Sereno; Edite Teixeira-Lemos; Sandra Ribeiro; Petronila Rocha-Pereira; Ethan Cotterill; Frederico Teixeira; Flávio Reis
Journal:  Dis Markers       Date:  2013-07-28       Impact factor: 3.434

10.  Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women.

Authors:  Hossein Darabi; Alireza Raeisi; Mohammad Reza Kalantarhormozi; Afshin Ostovar; Majid Assadi; Kamyar Asadipooya; Katayoun Vahdat; Sina Dobaradaran; Iraj Nabipour
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.